GLP-1 receptor agonists and SGLT-2 inhibitors are prescribed by some healthcare providers off-label for people with type 1 diabetes, but the ADA does not currently recommend them due to insufficient efficacy and safety data
IL-12, a robust TH1-inducing cytokine, has shown significant potential as a DNA vaccine adjuvant in both small and large animal studies and has proven to be safe and effective in humans [151,152,153]
In summary our study corroborate the outstanding role of IgE and its direct relationship in producing oxidative stress and subsequent bronchial inflammation in allergenic asthma patients
Ultimately, 10% to 30% of patients with LN progress to end stage renal disease requiring renal replacement therapy even with our current immune targeted therapies1,2
The goal isn't to create fear around these medications
Medical Students for Size Inclusivity have created an excelled GLP-1 informed consent guide here